169 Results (Page 7 of 7)
Mexico Markets Research Reports
Mexico Brugada Syndrome Market Analysis
The Mexico Brugada Syndrome Market was valued at $18 Mn in 2023 and is predicted to grow at a CAGR of 8.05% from 2023 to 2030, to $30.9 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Mexico Brugada Syndrome Market are Bayer, Roche, Teva, Medtronic, Abbott Laboratories, and Sanofi, among others.
Mexico Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Mexico Clinical Nutrition for Chronic Kidney Diseases Market was valued at $23.60 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $36.1 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and advancements in medical research. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Mexico Blood Disorder Therapeutics Market
Mexico Blood Disorder Therapeutics Market valued at $201 Mn in 2022, projected to reach $365 Mn by 2030 with a 7.75% CAGR. Growth in the market is being driven by Mexico's increasing prevalence of age-related blood diseases, unmet medical needs of the population as well as improvements in treatments like gene and targeted therapy. The Mexico Market encompasses various players across different segments, including Takeda, Sanofi, CSL Ltd, Pfizer, Celgene Corporation, Alexion Pharmaceuticals, Amgen, Laboratorios Grin, PiSA Pharmaceutical Company, Genomma Lab Internacional, etc, among various others.
Mexico Clinical Nutrition Market Analysis
The Mexico Clinical Nutrition Market was valued at $460.1 Mn in 2023 and is projected to grow at a CAGR of 5.59% from 2023 to 2023, to $673.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such Amway, Herbalife, and Nestle.
Mexico Breast Pump Market Report
The Mexico Breast Pump Market was valued at $44.1 Mn in 2023 and is predicted to grow at a CAGR of 8.85% from 2023 to 2030, to $79.8 Mn by 2030. The key drivers of the market include the emerging healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Mexico Breast Pump Market are Imani, Ardo, Ameda, Avent, and Evenflo, among others.
Mexico Cancer Induced Bone Disease Therapeutics Market
Mexico Cancer Induced Bone Disease Therapeutics Market valued at $20 Mn in 2022, projected to reach $31 Mn by 2030 with a 6.05% CAGR. The key drivers of this industry include the increasing incidence of cancer, improved diagnostics and treatment, and expanding treatment options. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Genomma, and Bayer among others.
Mexico Digital Biomarkers Market Analysis
Mexico Digital Biomarkers Market was valued at $43.50 Mn in 2023 and is predicted to grow at a CAGR of 22.55% from 2023 to 2030, to $180.59 Mn by 2030. The key drivers of this industry include rising chronic disease burden, increased smartphone penetration, growing focus on preventative care, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Mexico Medication Access Programs Market Analysis
The Mexico Medication Access Programs Market was valued at $82.3 Mn in 2023 and is predicted to grow at a CAGR of 14.85% from 2023 to 2030, to $217 Mn by 2030. The key drivers of this industry include healthcare reforms, disease burden, and government support. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Mexico Congestive Heart Failure Therapeutics Market Analysis
The Mexico Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $155 Mn in 2022 to $247 Mn by 2030, with a CAGR of 6.05% during the forecast period of 2022-2030. The key drivers of the market include the demographic trend of an aging population, lifestyle-related factors contributing to an increased incidence of heart failure, ongoing advancements in pharmaceutical research leading to novel therapies, and the significant impact of government initiatives. The Mexico Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Bayer, Bristol Myers Squibb, Novartis, Pfizer, Roche, Sanofi, PISA, Sanfer, Genomma Lab, etc, among various others.
Mexico Exosome Research Market Analysis
The Mexico Exosome Research Market was valued at $2.5 Mn in 2023 and is projected to grow at a CAGR of 16.25% from 2023 to 2023, to $7.3 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, NanoSomix, NX Pharmagen, Exosome Diagnostics among others.
Mexico Cardiac Resynchronization Therapy Market
Mexico Cardiac Resynchronization Therapy Market valued at $72 Mn in 2022, projected to reach $108 Mn by 2030 with a 5.25% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
Mexico Physiotherapy Equipment Market Analysis
The Mexico Physiotherapy Equipment Market was valued at $313.50 Mn in 2023 and is predicted to grow at a CAGR of 7.45% from 2023 to 2030, to $518.42 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, DJO Global, EMS Physio Ltd., and BTL Industries among others.
Mexico Biosensors Market Analysis
The Mexico Biosensors Market was valued at $433.5 Mn in 2023 and is predicted to grow at a CAGR of 8.25% from 2023 to 2030, to $755.1 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and increasing demand for accurate disease diagnosis. The prominent players of the Mexico Biosensors Market are Masimo Corporation, Meridian Bioscience, Biosensors International, Nix Biosensors, and Abbott Laboratories, among others.
Mexico Patient Adherence Programs Market Analysis
The Mexico Patient Adherence Programs Market was valued at $194.3 Mn in 2023 and is predicted to grow at a CAGR of 18.25% from 2023 to 2030, to $628.3 Mn by 2030. The key drivers of the market include. The prominent players in the Mexico Patient Adherence Programs Market are Grupo Neolpharma, PiSA Farmaceutica, Liomont, Laboratorios Sanfer, and Laboratorios Sophia, among others.
Mexico Dental Consumables Market Analysis
The Mexico Dental Consumables Market was valued at $507 Mn in 2023 and is projected to grow at a CAGR of 8.25% from 2023 to 2023, to $883.1 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, and changing living standards. The industry is primarily dominated by players such as Kerr Corporation, Kulzer Mexico, Dentsply Sirona, Danaher, Align Technology, Planmeca, J Morita, 3M, Carestream Dental among others.
Mexico LASIK Surgery Market Analysis
Mexico LASIK Surgery Market was valued at $52.95 Mn in 2023 and is predicted to grow at a CAGR of 5.46% from 2023 to 2030, to $76.82 Mn by 2030. The key drivers of this industry include rising prevalence, increasing awareness, and medical tourism. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Mexico Hemodialysis Vascular Grafts Market Analysis
Mexico Hemodialysis Vascular Grafts Market was valued at $3.14 Bn in 2023 and is predicted to grow at a CAGR of 5.35% from 2023 to 2030, to $4.52 Bn by 2030. The key drivers of this industry include the rising prevalence of diabetes and hypertension, the aging population, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Mexico Central Nervous System (CNS) Therapeutics Market Analysis
The Mexico Central Nervous System (CNS)Therapeutics Market was valued at $3.150 Bn in 2022 and is predicted to grow at a CAGR of 6.65% from 2023 to 2030, to $5.272 Bn by 2030. The key drivers of this industry include the rising burden of CNS disorders, increasing healthcare accessibility, and technological advancements. The industry is primarily dominated by players such as Pfizer, Sunovion, Biogen, Genomma, Eli Lilly, Teva, GSK, and Otsuka among others.
Mexico Hospital Market Analysis
The Mexico Hospital Market was valued at $82.49 Bn in 2023 and is predicted to grow at a CAGR of 7.85% from 2023 to 2030, to $140.01 Bn by 2030. The key drivers of this industry rise in rise in geriatric population, medical tourism, and government support. The key players in the industry are Galenia Hospital, Hospital Español, Médica Sur, and Star Médica Monterrey among others.